Yongying Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yongying Bai has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Binbin Yin
Department of Clinical Laboratory, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
10 shared publicationsJinghua Zhang
Department of Clinical Laboratory, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
10 shared publicationsYa Xi
Department of Central Laboratory, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China
8 shared publicationsKaiqi Wu
Department of Clinical Laboratory, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
4 shared publications- Bo Zhu
Department of Clinical Laboratory, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
3 shared publications Jiamin Huang
Department of Clinical Laboratory, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
2 shared publications
Latest Publications
- Open Access
- 29 August 2026
- Published by Springer Nature in Journal of Health, Population and Nutrition
Association between TyHGB and gestational diabetes mellitus: a large-scale retrospective cross-sectional study
- 29 August 2026
- Published by Springer Nature in Journal of Health, Population and Nutrition
Open AccessAssociation between TyHGB and gestational diabetes mellitus: a large-scale retrospective cross-sectional study
- Open Access
- 27 April 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25 (1)
TyHGB as a predictive marker for preeclampsia: association with increased risk in pregnant women with normal glucose tolerance
Insulin resistance (IR) is considered a crucial pathophysiological driver of preeclampsia. The triglyceride high-density cholesterol-glucose body index (Ty
- 27 April 2026
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 25 (1)
Open AccessTyHGB as a predictive marker for preeclampsia: association with increased risk in pregnant women with normal glucose tolerance
Insulin resistance (IR) is considered a crucial pathophysiological driver of preeclampsia. The triglyceride high-density cholesterol-glucose body index (Ty
- Open Access
- 26 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (39) , e44778
Atypical glucose response patterns in pregnant women and the association with hypertensive disorders of pregnancy: A retrospective analysis
The oral glucose tolerance test (OGTT) is crucial for diagnosing gestational diabetes mellitus (GDM), yet traditional screening overlooks OGTT curve shapes. Hypertensive disorders of pregnancy (HDP) are common and hyperglycemia is a risk factor, but the relationship between glucose response patterns during OGTT and HDP, remains underexplored. A retrospective cohort study was conducted on 26,084 pregnant women undergoing 75-gram OGTT at 24 to 28 weeks’ gestation. Glucose curves were classified as incessant increase (IIn, continuous increase at 0, 1, and 2 hours) or monophasic (MPh, peak at 1 hour followed by decrease). Multivariable logistic regression evaluated crude and adjusted relative risks (RRs) of HDP, adjusting for maternal age, preconception body mass index (BMI), parity, in vitro fertilization (IVF), gestational weight gain (GWG), birth weight, gestational age, and GDM status. Subgroup analyses stratified by age categories, BMI categories, and GDM status were performed. The IIn pattern was observed in 14.46% of participants. Compared with the MPh group, the IIn group demonstrated a significantly lower crude RR of HDP [0.70, 95% confidence interval (CI): 0.59–0.84, P < .001], which persisted after adjustment for confounding variables (adjusted RR = 0.74, 95% CI: 0.61–0.89, P < .01). Stratified analysis demonstrated consistent protective effects of IIn curves across maternal age subgroups, as well as among women with and without GDM. The IIn glucose response curve is independently associated with reduced HDP risk, suggesting its potential as a biomarker for personalized risk assessment.
- 26 September 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (39) , e44778
Open AccessAtypical glucose response patterns in pregnant women and the association with hypertensive disorders of pregnancy: A retrospective analysis
The oral glucose tolerance test (OGTT) is crucial for diagnosing gestational diabetes mellitus (GDM), yet traditional screening overlooks OGTT curve shapes. Hypertensive disorders of pregnancy (HDP) are common and hyperglycemia is a risk factor, but the relationship between glucose response patterns during OGTT and HDP, remains underexplored. A retrospective cohort study was conducted on 26,084 pregnant women undergoing 75-gram OGTT at 24 to 28 weeks’ gestation. Glucose curves were classified as incessant increase (IIn, continuous increase at 0, 1, and 2 hours) or monophasic (MPh, peak at 1 hour followed by decrease). Multivariable logistic regression evaluated crude and adjusted relative risks (RRs) of HDP, adjusting for maternal age, preconception body mass index (BMI), parity, in vitro fertilization (IVF), gestational weight gain (GWG), birth weight, gestational age, and GDM status. Subgroup analyses stratified by age categories, BMI categories, and GDM status were performed. The IIn pattern was observed in 14.46% of participants. Compared with the MPh group, the IIn group demonstrated a significantly lower crude RR of HDP [0.70, 95% confidence interval (CI): 0.59–0.84, P < .001], which persisted after adjustment for confounding variables (adjusted RR = 0.74, 95% CI: 0.61–0.89, P < .01). Stratified analysis demonstrated consistent protective effects of IIn curves across maternal age subgroups, as well as among women with and without GDM. The IIn glucose response curve is independently associated with reduced HDP risk, suggesting its potential as a biomarker for personalized risk assessment.
- Open Access
- 6 August 2025
- Published by Elsevier in Endocrine Practice
- Vol. 32 (1) , 2-10
Can Maternal Hypoglycemia During Oral Glucose Tolerance Test Predict Adverse Pregnancy Outcomes?
- 6 August 2025
- Published by Elsevier in Endocrine Practice
- Vol. 32 (1) , 2-10
Open AccessCan Maternal Hypoglycemia During Oral Glucose Tolerance Test Predict Adverse Pregnancy Outcomes?
- Open Access
- 11 July 2025
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 104 (10) , 1918-1928
The flat glucose response curve during oral glucose tolerance tests in Chinese pregnant women and its association with adverse outcomes
Introduction: Flat glucose response curves observed during the oral glucose tolerance test (OGTT) in pregnant women are relatively prevalent. This study aimed to investigate the characteristics and perinatal outcomes of Chinese women who presented with flat OGTT curves during pregnancy.Material and Methods: A total of 23 576 pregnant women without gestational diabetes mellitus (GDM) were recruited into this study. They were classified into two groups according to the shape of their glucose response curves obtained from OGTTs performed at 24–28 weeks of gestation. The curves were categorized as either flat or normal. Specifically, a flat curve was defined as a less than 16.5% increase in plasma glucose levels during the OGTT, while all other curves were regarded as normal. Logistic regression analysis was employed to examine the associations between these curve types and the risk of perinatal outcomes. Additionally, these relationships were evaluated across different maternal age groups and preconception body mass index (BMI) categories.Results: Among the participants, 932 (3.95%) displayed a flat curve, while 22 644 (96.05%) showed a normal curve. Women with a flat curve were significantly younger (p < 0.001) and had a lower BMI (p < 0.001). Compared with those with a normal curve, women with a flat curve had lower incidences of gestational hypertension and preeclampsia. Additionally, neonates born to mothers with a flat curve had lower birth weights and lower occurrences of large for gestational age (LGA) and macrosomia. Logistic regression analyses, using the normal‐curve group as the reference, demonstrated that, regardless of confounder adjustments, the flat‐curve group was associated with a protective effect against gestational hypertension, preeclampsia, LGA, and macrosomia development (all p < 0.05). Moreover, these risks differed according to maternal age and preconception BMI. No significant differences were observed in other maternal or neonatal outcomes.Conclusions: A flat OGTT curve is associated with lower birth weight and reduced risks of LGA, macrosomia, gestational hypertension, and preeclampsia. Identifying the flat curve as a protective factor for LGA, macrosomia, gestational hypertension, and preeclampsia, particularly among women with different maternal ages and preconception BMIs, may facilitate personalized risk assessment and management.
- 11 July 2025
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 104 (10) , 1918-1928
Open AccessThe flat glucose response curve during oral glucose tolerance tests in Chinese pregnant women and its association with adverse outcomes
Introduction: Flat glucose response curves observed during the oral glucose tolerance test (OGTT) in pregnant women are relatively prevalent. This study aimed to investigate the characteristics and perinatal outcomes of Chinese women who presented with flat OGTT curves during pregnancy.Material and Methods: A total of 23 576 pregnant women without gestational diabetes mellitus (GDM) were recruited into this study. They were classified into two groups according to the shape of their glucose response curves obtained from OGTTs performed at 24–28 weeks of gestation. The curves were categorized as either flat or normal. Specifically, a flat curve was defined as a less than 16.5% increase in plasma glucose levels during the OGTT, while all other curves were regarded as normal. Logistic regression analysis was employed to examine the associations between these curve types and the risk of perinatal outcomes. Additionally, these relationships were evaluated across different maternal age groups and preconception body mass index (BMI) categories.Results: Among the participants, 932 (3.95%) displayed a flat curve, while 22 644 (96.05%) showed a normal curve. Women with a flat curve were significantly younger (p < 0.001) and had a lower BMI (p < 0.001). Compared with those with a normal curve, women with a flat curve had lower incidences of gestational hypertension and preeclampsia. Additionally, neonates born to mothers with a flat curve had lower birth weights and lower occurrences of large for gestational age (LGA) and macrosomia. Logistic regression analyses, using the normal‐curve group as the reference, demonstrated that, regardless of confounder adjustments, the flat‐curve group was associated with a protective effect against gestational hypertension, preeclampsia, LGA, and macrosomia development (all p < 0.05). Moreover, these risks differed according to maternal age and preconception BMI. No significant differences were observed in other maternal or neonatal outcomes.Conclusions: A flat OGTT curve is associated with lower birth weight and reduced risks of LGA, macrosomia, gestational hypertension, and preeclampsia. Identifying the flat curve as a protective factor for LGA, macrosomia, gestational hypertension, and preeclampsia, particularly among women with different maternal ages and preconception BMIs, may facilitate personalized risk assessment and management.
- Open Access
- 23 April 2025
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 44 (1) , 1-13
Association between the glucose pattern in oral glucose tolerance test and adverse pregnancy outcomes among non-diabetic women
This study aimed to explore whether the patterns of the oral glucose tolerance test (OGTT) could function as a predictive factor for adverse pregnancy outcomes in pregnant women without gestational diabetes mellitus (GDM). A retrospective cohort study was carried out, involving a total of 23,577 pregnant women. The participants were classified into three groups according to the area under the curve (AUC) of the OGTT performed between 24 and 28 weeks of gestation. Based on the tertiles of the AUC-OGTT magnitude, three distinct glucose patterns were identified: small AUC (SA) with an AUC-OGTT ≤ 12.26, medium AUC (MA) with an AUC-OGTT between 12.26 and 13.81, and large AUC (LA) with an AUC-OGTT > 13.81. Logistic regression analysis was utilized to assess the association between different AUC-OGTT patterns and the risk of adverse pregnancy outcomes. The incidence of adverse pregnancy outcomes, including preeclampsia, preterm birth, macrosomia, and cesarean delivery, showed a progressive increase from the SA to the MA to the LA pattern. A positive dose-response relationship was observed between the AUC-OGTT and adverse pregnancy outcomes. In the logistic regression analysis, with the SA pattern as the reference, the MA pattern was associated with a higher risk of macrosomia and cesarean delivery (both P < 0.001). Even after adjusting for potential covariates, the relative risks for these outcomes were 1.34 (95% CI: 1.14, 1.56) and 1.09 (95% CI: 1.01, 1.16), respectively (both P < 0.05). Additionally, the LA pattern was associated with a higher risk of preeclampsia, preterm birth, macrosomia, and cesarean delivery (all P < 0.01). After adjusting for potential covariates, the relative risks for preterm birth, macrosomia, and cesarean delivery were 1.20 (95% CI: 1.03, 1.41), 1.68 (95% CI: 1.44, 1.95), and 1.15 (95% CI: 1.07, 1.23), respectively (all P < 0.05). Moreover, these risks differed according to maternal age and preconception body mass index (BMI). The present study highlights the relationship between OGTT patterns and adverse pregnancy outcomes in Chinese women without GDM. Identifying the MA and LA patterns as unfavorable factors for adverse pregnancy outcomes can provide crucial information for clinicians to develop personalized risk assessment and intervention strategies, which may contribute to improving pregnancy outcomes.
- 23 April 2025
- Published by Springer Nature in Journal of Health, Population and Nutrition
- Vol. 44 (1) , 1-13
Open AccessAssociation between the glucose pattern in oral glucose tolerance test and adverse pregnancy outcomes among non-diabetic women
This study aimed to explore whether the patterns of the oral glucose tolerance test (OGTT) could function as a predictive factor for adverse pregnancy outcomes in pregnant women without gestational diabetes mellitus (GDM). A retrospective cohort study was carried out, involving a total of 23,577 pregnant women. The participants were classified into three groups according to the area under the curve (AUC) of the OGTT performed between 24 and 28 weeks of gestation. Based on the tertiles of the AUC-OGTT magnitude, three distinct glucose patterns were identified: small AUC (SA) with an AUC-OGTT ≤ 12.26, medium AUC (MA) with an AUC-OGTT between 12.26 and 13.81, and large AUC (LA) with an AUC-OGTT > 13.81. Logistic regression analysis was utilized to assess the association between different AUC-OGTT patterns and the risk of adverse pregnancy outcomes. The incidence of adverse pregnancy outcomes, including preeclampsia, preterm birth, macrosomia, and cesarean delivery, showed a progressive increase from the SA to the MA to the LA pattern. A positive dose-response relationship was observed between the AUC-OGTT and adverse pregnancy outcomes. In the logistic regression analysis, with the SA pattern as the reference, the MA pattern was associated with a higher risk of macrosomia and cesarean delivery (both P < 0.001). Even after adjusting for potential covariates, the relative risks for these outcomes were 1.34 (95% CI: 1.14, 1.56) and 1.09 (95% CI: 1.01, 1.16), respectively (both P < 0.05). Additionally, the LA pattern was associated with a higher risk of preeclampsia, preterm birth, macrosomia, and cesarean delivery (all P < 0.01). After adjusting for potential covariates, the relative risks for preterm birth, macrosomia, and cesarean delivery were 1.20 (95% CI: 1.03, 1.41), 1.68 (95% CI: 1.44, 1.95), and 1.15 (95% CI: 1.07, 1.23), respectively (all P < 0.05). Moreover, these risks differed according to maternal age and preconception body mass index (BMI). The present study highlights the relationship between OGTT patterns and adverse pregnancy outcomes in Chinese women without GDM. Identifying the MA and LA patterns as unfavorable factors for adverse pregnancy outcomes can provide crucial information for clinicians to develop personalized risk assessment and intervention strategies, which may contribute to improving pregnancy outcomes.
- Open Access
- 28 February 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 22 (1) , 195-207
The rare glucose response curve during oral glucose tolerance tests in pregnant Chinese women and its association with preterm birth
Introduction: This study aimed to investigate the rare glucose response curve during oral glucose tolerance tests (OGTTs) in pregnant Chinese women and its association with preterm birth.Material and methods: A total of 26,092 pregnant women were included in this study and categorized into two groups based on the shape of their glucose response curve during OGTTs conducted at 24–28 weeks of gestation. The curves were classified as either monophasic (MPh) or incessant increase (IIn). Logistic regression analysis was utilized to examine the association between these shapes and the risk of preterm birth. Additionally, we explored the relationship between these shapes and preterm birth across various factors including gestational diabetes mellitus (GDM) status, maternal age, preconception body mass index (BMI), and gestational weight gain (GWG).Results: The most prevalent OGTT curve observed was MPh (85.54%), followed by IIn (14.46%). Compared to the majority MPh group, curves with IIn had a higher rate of preterm birth (p < 0.05). The logistic regression analyses, with the MPh group as a reference, revealed that regardless of GDM, membership of the IIn group was an unfavorable factor for preterm birth development, even after adjusting for potential covariates (p < 0.05). Furthermore, these risks varied depending on maternal age, preconception BMI, and GWG.Conclusions: This study establishes a significant correlation between the rare glucose response curve and the risk of preterm birth. Identifying IIn curves as an unfavorable factor for preterm birth, particularly among women with varying maternal ages, BMI, and GWG, holds substantial potential value for personalized risk assessment and intervention strategies.
- 28 February 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 22 (1) , 195-207
Open AccessThe rare glucose response curve during oral glucose tolerance tests in pregnant Chinese women and its association with preterm birth
Introduction: This study aimed to investigate the rare glucose response curve during oral glucose tolerance tests (OGTTs) in pregnant Chinese women and its association with preterm birth.Material and methods: A total of 26,092 pregnant women were included in this study and categorized into two groups based on the shape of their glucose response curve during OGTTs conducted at 24–28 weeks of gestation. The curves were classified as either monophasic (MPh) or incessant increase (IIn). Logistic regression analysis was utilized to examine the association between these shapes and the risk of preterm birth. Additionally, we explored the relationship between these shapes and preterm birth across various factors including gestational diabetes mellitus (GDM) status, maternal age, preconception body mass index (BMI), and gestational weight gain (GWG).Results: The most prevalent OGTT curve observed was MPh (85.54%), followed by IIn (14.46%). Compared to the majority MPh group, curves with IIn had a higher rate of preterm birth (p < 0.05). The logistic regression analyses, with the MPh group as a reference, revealed that regardless of GDM, membership of the IIn group was an unfavorable factor for preterm birth development, even after adjusting for potential covariates (p < 0.05). Furthermore, these risks varied depending on maternal age, preconception BMI, and GWG.Conclusions: This study establishes a significant correlation between the rare glucose response curve and the risk of preterm birth. Identifying IIn curves as an unfavorable factor for preterm birth, particularly among women with varying maternal ages, BMI, and GWG, holds substantial potential value for personalized risk assessment and intervention strategies.
- Open Access
- 11 January 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2452352
Impact of time from blood specimens collection to centrifugation on the diagnosis of gestational diabetes mellitus
The process of glycolysis from blood collection to centrifugation impacts the diagnosis of gestational diabetes mellitus (GDM). However, the specific characteristics of the working environment in China and its influence on GDM diagnosis still need to be clarified. Firstly, 15 pregnant women were recruited, and six specimens were collected from each in a fasting state. The specimens were left at room temperature for different times (0.5, 1, 2, 3, 4, and 5 h) and then centrifuged. Subsequently, data were collected from pregnant women who underwent oral glucose tolerance test (OGTT) between June 1, 2021, and July 30, 2022. Pregnant women were categorized into different groups based on different pre-treatment times, and the incidence of GDM was calculated for each group. Glucose levels gradually decreased as the specimen remained longer before centrifugation, a decrease of 1.15 mmol/L (27.58%) from the initial glucose level (3.02 ± 0.30 mmol/L VS. 4.17 ± 0.28 mmol/L, p < 0.001). 2-h specimens had the longest pre-treatment time (29.92 ± 14.94 min (min)), accounting for half of the specimens exceeding 90 min. The longer the specimen pre-treatment time, the greater the impact on the diagnosis of GDM. Timely centrifugation prevented 3.42%, 3.35%, and 2.21% missed GDM diagnoses. In the Chinese healthcare environment, prolonging specimen pre-treatment time can affect GDM diagnosis. Therefore, standardizing specimen pre-treatment is crucial to minimize potential effects.
- 11 January 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1) , 2452352
Open AccessImpact of time from blood specimens collection to centrifugation on the diagnosis of gestational diabetes mellitus
The process of glycolysis from blood collection to centrifugation impacts the diagnosis of gestational diabetes mellitus (GDM). However, the specific characteristics of the working environment in China and its influence on GDM diagnosis still need to be clarified. Firstly, 15 pregnant women were recruited, and six specimens were collected from each in a fasting state. The specimens were left at room temperature for different times (0.5, 1, 2, 3, 4, and 5 h) and then centrifuged. Subsequently, data were collected from pregnant women who underwent oral glucose tolerance test (OGTT) between June 1, 2021, and July 30, 2022. Pregnant women were categorized into different groups based on different pre-treatment times, and the incidence of GDM was calculated for each group. Glucose levels gradually decreased as the specimen remained longer before centrifugation, a decrease of 1.15 mmol/L (27.58%) from the initial glucose level (3.02 ± 0.30 mmol/L VS. 4.17 ± 0.28 mmol/L, p < 0.001). 2-h specimens had the longest pre-treatment time (29.92 ± 14.94 min (min)), accounting for half of the specimens exceeding 90 min. The longer the specimen pre-treatment time, the greater the impact on the diagnosis of GDM. Timely centrifugation prevented 3.42%, 3.35%, and 2.21% missed GDM diagnoses. In the Chinese healthcare environment, prolonging specimen pre-treatment time can affect GDM diagnosis. Therefore, standardizing specimen pre-treatment is crucial to minimize potential effects.
- Open Access
- 12 March 2024
- Published by Elsevier in Preventive Medicine Reports
- Vol. 41, 102683
Triglyceride-glucose index: A promising biomarker for predicting risks of adverse pregnancy outcomes in Hangzhou, China
- 12 March 2024
- Published by Elsevier in Preventive Medicine Reports
- Vol. 41, 102683
Open AccessTriglyceride-glucose index: A promising biomarker for predicting risks of adverse pregnancy outcomes in Hangzhou, China
- Open Access
- 26 January 2024
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 23 (1) , 1-9
Triglyceride-glucose index is a risk factor for breast cancer in China: a cross-sectional study
Background: This research delved into the association between the risk of the Chinese population suffering from breast cancer (BC) and the triglyceride-glucose (TyG) index. Methods: A total of 2,111 sufferers with benign breast disease (BBD) and 477 sufferers with BC were enrolled, and their TyG index was measured. Participants with varying TyG index values were categorized into quartiles. Logistic regression analysis was employed to assess the relationship between the TyG index and BC risk. The diagnostic performance of the TyG index for different stages of BC was measured using the receiver operating characteristic (ROC) curve. Results: The TyG index of BC sufferers exceeded that of BBD (P < 0.001). A continuous increase in the risk of BC was found to be positively correlated with an ever-increasing TyG index. In the unadjusted model, the risk of getting BC mounted with quartiles of the TyG index growing (P < 0.001). In a logistic regression analysis that included all confounders, the highest quartile of the TyG index was strongly linked to BC risk [1.43 (1.01, 2.02), P < 0.05]. Moreover, with the adjustment of potential confounders, a high TyG index was found to result in a 2.53-fold higher risk of being diagnosed with advanced BC. Conclusions: The risen TyG index was positively correlated to the heightening risk of BC and had the potential to serve as a promising biomarker for BC. Individuals with a high TyG index ought to be mindful of the heightened risk of BC onset and progression.
- 26 January 2024
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 23 (1) , 1-9
Open AccessTriglyceride-glucose index is a risk factor for breast cancer in China: a cross-sectional study
Background: This research delved into the association between the risk of the Chinese population suffering from breast cancer (BC) and the triglyceride-glucose (TyG) index. Methods: A total of 2,111 sufferers with benign breast disease (BBD) and 477 sufferers with BC were enrolled, and their TyG index was measured. Participants with varying TyG index values were categorized into quartiles. Logistic regression analysis was employed to assess the relationship between the TyG index and BC risk. The diagnostic performance of the TyG index for different stages of BC was measured using the receiver operating characteristic (ROC) curve. Results: The TyG index of BC sufferers exceeded that of BBD (P < 0.001). A continuous increase in the risk of BC was found to be positively correlated with an ever-increasing TyG index. In the unadjusted model, the risk of getting BC mounted with quartiles of the TyG index growing (P < 0.001). In a logistic regression analysis that included all confounders, the highest quartile of the TyG index was strongly linked to BC risk [1.43 (1.01, 2.02), P < 0.05]. Moreover, with the adjustment of potential confounders, a high TyG index was found to result in a 2.53-fold higher risk of being diagnosed with advanced BC. Conclusions: The risen TyG index was positively correlated to the heightening risk of BC and had the potential to serve as a promising biomarker for BC. Individuals with a high TyG index ought to be mindful of the heightened risk of BC onset and progression.